Abstract
Background
Pregnancy with invasive gynecologic cancer is a rare condition. It is still unclear whether we can choose planned delay in treatment until maturation of the fetus as a treatment modality for this condition. If there are no adverse effects from the cancer and there is improvement of neonatal outcomes, this treatment modality might be an option for patients with this condition.
Methods
Eight pregnant patients were diagnosed as having invasive gynecologic cancer between January 1998 and December 2007. Five of them, (four with invasive uterine cervical cancer and one with ovarian cancer) chose planned delay in treatment. The pregnancy courses and prognoses of these patients were studied.
Results
The period of planned delay in treatment varied from 2 weeks to 19 weeks. The period was shorter for patients who had complications. The pain caused by the cancer was the main obstacle to this treatment modality in two patients (one with advanced ovarian cancer and one with uterine cervical cancer). No apparent tumor growth, elevation of tumor markers, or complications induced by the cancer itself were detected in the remaining three patients. Only the patient with advanced ovarian cancer died of the primary disease after the delivery. Fetal outcome was uniformly good for the delayed-treatment group. All the babies are growing well, and no fetal deaths or neonatal deaths occurred.
Conclusion
Planned delay in treatment to allow for fetal maturity is acceptable in pregnant patients with certain types of invasive gynecologic cancers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Pavlidis NA (2002) Coexistence of pregnancy and malignancy. Oncologist 7:279–287
Germann N, Haie-Meder C, Morice P, et al. (2005) Management and clinical outcomes of pregnant patients with invasive cervical cancer. Ann Oncol 16:397–402
Sorosky JI, Squatrito R, Ndubisi BU, et al. (1995) Stage I squamous cell cervical carcinoma in pregnancy: planned delay in therapy awaiting fetal maturity. Gynecol Oncol 59:207–210
Takushi M, Moromizato H, Sakumoto K, et al. (2002) Management of invasive carcinoma of the uterine cervix associated with pregnancy: outcome of intentional delay in treatment. Gynecol Oncol 87:185–189
Ishioka S, Hayashi T, Endo T, et al. (2007) Advanced epithelial ovarian carcinoma during pregnancy. Int J Clin Oncol 12: 375–378
Bray F, Carstensen B, Møller H, et al. (2005) Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 14:2191–2199
Eifel PJ, Burke TW, Morris M, et al. (1995) Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 59:38–44
Degefu S, O’Quinn AG, Lacey CG et al. (1986) Verrucous carcinoma of the cervix: a report of two cases and literature review. Gynecol Oncol 25:37–47
Zanotti KS, Belinson JL, Kennedy AW (2000). Treatment of gynecologic cancers in pregnancy. Semin Oncol 27:686–698
Rakic S, Nikolic B, Dragojevic-ikic S (2005) Ovarian neoplasms and pregnancy. Int J Gynecol Cancer 15:1120–1123
Beeley L (1988) Adverse effects of drugs in the first trimester of pregnancy. Clin Obstet Gynecol 13:177–195
Malfetano JH, Goldkrand JW (1990) Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma. Obstet Gynecol 75:545–547
Picone O, Lhomme C, Tournaire M, et al. (2004) Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: case report and literature review. Gynecol Oncol 94:600–604
Karam A, Feldman N, Holschneider CH (2007) Neoadjuvant cisplatin and radical cesarean hysterectomy for cervical cancer in pregnancy. Nat Clin Pract Oncol 4:375–380
Serenius F, Ewald U, Farooqi A, et al. (2004) Short-term outcome after active perinatal management at 23–25 weeks of gestation. A study from two Swedish tertiary care centres. Part 1: maternal and obstetric factors. Acta Paediatr 93:945–953
Ikenoue T (1986) The maternal, fetal and neonatal clinical characteristics in cases delivered between 24 and 32 weeks’ gestation Nippon Sanka Fujinka Gakkai Zasshi 38:1198–1208
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ishioka, Si., Ezaka, Y., Endo, T. et al. Outcomes of planned delivery delay in pregnant patients with invasive gynecologic cancer. Int J Clin Oncol 14, 321–325 (2009). https://doi.org/10.1007/s10147-008-0861-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-008-0861-4